The Directors of the IHRB, at their Board Meeting on 11 December 2024 approved the following changes to Rule 278 (vi) (a) which will become effective on 12 December 2024:  

1. (vi) The procedure upon the receipt of Dope Test results shall be as set out in this Rule. 

(a) 

1. Any Rider whose "A" sample discloses the presence of a Banned Substance or use of a Banned Method shall be so notified in writing by the Doping Control Officer.  The Rider shall have the right to request that their "B" sample be analysed to determine whether that sample discloses the same Banned Substance(s) or use of a Banned Method detected in the "A" sample.  [text deleted] 

1. Save as otherwise provided in this Rule, the cost of the "B" sample analysis and all reasonable related administrative, legal, and ancillary costs shall be borne by the Rider. Any such request must be made within fourteen days of the said notification to the Rider. The IHRB shall provide an itemised breakdown of these costs within a reasonable time, specifying the payment deadline and demand. Where any dispute arises regarding the liability or amount of these costs, it shall be determined by the Referrals Committee at the hearing with an appeal against such determinations thereafter to the Appeals Body in accordance with the general provisions relating to Appeals in these Rules.  

1. In the event that the Rider fails to pay such costs within the specified payment deadline, the IHRB shall have the right to take enforcement action including but not limited to refusing to issue or renew any licenses or permits held by the Rider, or taking legal action to recover the costs through summary proceedings in any court of competent jurisdiction in Ireland.